Quogue Capital LLC Q4 2014 significant ownership

Quogue Capital LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Quogue Capital LLC Q4 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
INFINITY PHARMACEUTICALS, INC.^{Sold out}	June 27, 2013	0	0.0%
PALATIN TECHNOLOGIES INC^{Sold out}	February 14, 2013	0	0.0%
REPROS THERAPEUTICS INC.^{Sold out}	February 07, 2013	0	0.0%
PALATIN TECHNOLOGIES INC	February 28, 2011	3,646,391	9.9%
Endo Pharmaceuticals Solutions Inc.^{Sold out}	February 14, 2011	0	0.0%
PHARMACYCLICS INC	February 14, 2011	1,500,000	2.5%
Talon Therapeutics, Inc.	February 14, 2011	876,206	3.9%
PENWEST PHARMACEUTICALS CO^{Sold out}	February 27, 2009	0	0.0%
REPROS THERAPEUTICS INC.^{Sold out}	February 14, 2007	0	0.0%

Compare quarters

Export Quogue Capital LLC's holdings